Merck has joined the ranks of Big Pharma companies dramatically cutting their sales forces, planning to let go about 1,200 reps (14% of the sales force) after problems with Vytorin, and non-approval of Cordaptive.
More on the story here.
This makes me think about doing a post on Networking: Preparing for the Future or something along those lines (OK, here it is!). Pro-actively building a supportive professional network of contacts seems to me not to be an optional move anymore. Things are too uncertain, even for good performers…
Leave a Reply